Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Champ Resto Indonesia Tbk. (ENAK) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Champ Resto Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Champ Resto Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Champ Resto Indonesia Tbk. trades at Rp234 (market cap 520B, 529.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Champ Resto Indonesia Tbk. is far larger — about 3.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Champ Resto Indonesia Tbk. is more actively traded (529.9K versus 62.5K). Which is the better fit depends on your goals.

ENAKOBAT
Market Cap
520B164.65B
Volume
529.9K62.5K
Lot
5.3K625
Turnover
125.86M15.03M
Average Price
237.52240.55
Value
125.86M15.03M
Indicative Equilibrium Price
240238
Indicative Equilibrium Volume
4.4K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ENAK
View details
OBAT
View details

About Champ Resto Indonesia Tbk.

PT Champ Resto Indonesia Tbk ("Company") was established based on the Notarial Deed of Catherina Situmorang, S.H., No. 20 dated March 22, 2010.

Read more on ENAK

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT